Bumrungrad Hospital (BH TB): Lower Revenue From International Patients Weighed on 3Q24 Result
Bumrungrad reported 5% YoY sales decline in 3Q24, mainly due to negative geo-political impact on international patient revenue, which declined 7%...
333 Views
Bumrungrad Hospital - Downbeat 3Q24 Earnings; 4Q24E to Fall Further QoQ
We upgrade our rating to Neutral (previously Underperform) with a more positive outlook on both the fundamental and tactical aspects.
150 Views
Bumrungrad Hospital - Low 3-Year Earnings Growth
KTX has assessed a fair value of Bt242.00, based on the earnings yield method and a required return of 3.9%, which equates to a P/E ratio of 26x.
307 Views
ECM Weekly (16th Sep 2024) - Midea, Bajaj Housing, 99 Speed, P N Gadgil, Hozon, Trial, NextDC, Via
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
487 Views
Special Report – Vayupak Fund 1 (VAYU1)
KTX expects that the sale of Type A investment units of the Vayupak 1 Fund (VAYU1), scheduled for September 16-20, will meet the target of Bt150bn
474 Views